Skip to content
OpenCapital
Get started

Innovate VATE Redeemable NCI

Redeemable NCI at other companies

VMI
Valmont IndustriesVMI
$9.3M-83.7%

Other financials

Income statement

See full
Revenue$364.8M+33.0%
Gross profit$53.5M+17.6%
Operating income$10.0M+194%
Net income-$16.8M+31.4%
EPS (diluted)-$1.29+31.7%

Balance sheet

See full
Cash & equivalents$134.6M+297%
Total debt$1.4B+11.6%
Total equity-$256.3M-25.5%
Total assets$936.8M+7.9%

Cash flow

See full
Operating cash flow$45.5M+423%
CapEx$200.0K-95.7%
Free cash flow$45.3M+341%

Valuation

See full
Market cap$254.69M+274%

Where this comes from

Reported directly by Innovate in its filing.

Tagged under the XBRL concept us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests.

The official record: Innovate’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innovate's redeemable nci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innovate's redeemable NCI?
Innovate (VATE) reported redeemable NCI of $10.8M in Q1 2026.
How has Innovate's redeemable NCI changed year-over-year?
Innovate's redeemable NCI decreased by 29.9% year-over-year, from $15.4M to $10.8M.
What is the long-term trend for Innovate's redeemable NCI?
Over 5 years (2020 to 2025), Innovate's redeemable NCI has grown at a -7.0% compound annual growth rate (CAGR), from $15.7M to $10.9M.
What does redeemable NCI mean?
Minority interests in subsidiaries that include a put option allowing the minority holder to require the parent to repurchase their stake.